Published Date: 13 Nov 2025
A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give ...
Read Full NewsBritish lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.
Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.
Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.
In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.
For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.
1.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
2.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
3.
Obesity linked to subsequent neoplasms in childhood cancer survivors
4.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
5.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
1.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
2.
Exploring the Potential of Bendamustine in Cancer Treatment
3.
Multimodal Tumor Response Modeling: Integrating Mechanistic, Clinical, and Computational Approaches
4.
Magnetically Controlled Surgical Microdevices for Targeted Hematologic Tissue Intervention
5.
Quality of Life Following Functional Hematopoietic Recovery
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
Best Practices in Hematology
3.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
5.
Recognizing the Signs of Anemia in Adults
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation